Long‐term safety and activity of NY-ESO‐1 SPEAR T cells after autologous stem cell transplant for myeloma

This study in patients with relapsed, refractory, or high-risk multiple myeloma (MM) evaluated the safety and activity of autologous T cells engineered to express an affinity-enhanced T-cell receptor (TCR) that recognizes a peptide shared by cancer antigens New York esophageal squamous cell carcinom...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood Adv
Autori principali: Stadtmauer, Edward A., Faitg, Thomas H., Lowther, Daniel E., Badros, Ashraf Z., Chagin, Karen, Dengel, Karen, Iyengar, Malini, Melchiori, Luca, Navenot, Jean-Marc, Norry, Elliot, Trivedi, Trupti, Wang, Ruoxi, Binder, Gwendolyn K., Amado, Rafael, Rapoport, Aaron P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2019
Soggetti:
Gene Therapy
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6616263/
https://ncbi.nlm.nih.gov/pubmed/31289029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000194
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi